查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1495443

氟二酮市場：按純度、應用和最終用戶 - 2024-2030 年全球預測

Fluindione Market by Purity (95%, >= 98%), Application (Anticoagulating Treatment, Permanent Atrial Fibrillation, Pulmonary Embolism), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年Fluindione市場規模為9.199億美元，預計2024年將達到9.7151億美元，2030年將達到13.5551億美元，複合年成長率為5.69%。

氟二酮市場是指主要集中在氟二酮的生產、分銷和應用的全球產業格局，氟二酮是一種用於治療和預防血栓栓塞性疾病的口服抗凝血劑。該市場包括製藥公司、醫療保健提供者、研究機構和需要抗凝血治療的患者。傳統上，氟二酮在臨床環境中用於預防和控制患者的血栓症和栓塞。其應用也擴展到需要長期抗凝血治療的患者，例如心房顫動、靜脈血栓栓塞症以及血栓形成高風險的患者。氟吲二酮市場的成長受到心血管疾病盛行率上升、醫學研究的進步、全球醫療基礎設施的改善和擴展以及對血栓性栓塞症的認知不斷提高等因素的影響。然而，由於氟二酮的潛在副作用，包括出血風險和藥物交互作用，市場面臨限制。監管挑戰、嚴格的核准流程以及新抗凝血劑的競爭是主要障礙。此外，患者對長期抗凝血治療的依從性仍是一個挑戰。同時，氟二酮擴張的機會在於開發具有更高功效和安全性的氟二酮衍生物、製藥公司與研究機構之間的戰略聯盟以及全球新型藥物輸送系統的持續開發。

主要市場統計
基準年[2023] 9.199 億美元
預測年份 [2024] 97151萬美元
預測年份 [2030] 1,355.51 百萬美元
複合年成長率（%） 5.69%

區域洞察

在北美，尤其是在美國，心血管疾病的盛行率正在增加，導致對抗凝劑的巨大需求。美國消費者的行為深受臨床醫師建議的影響，並且越來越青睞副作用較少、患者預後較好的藥物。兩國的研究都很活躍，每年都有大量的專利申請，這顯示兩國的技術創新活躍，競爭環境良好。由於醫療基礎設施的改善以及人們對需要抗凝血治療的疾病的認知不斷提高，南美市場呈現適度成長。由於完善的醫療保健系統和對血栓栓塞性疾病的高度認知，歐洲國家傳統上一直是氟二酮的強勁市場。尤其是法國，在氟二酮市場佔有重要地位，並採取了研究和開發舉措。中東和非洲是多元化的，海灣國家由於醫療保健投資的增加和更容易獲得的醫療保健服務而顯示出市場擴張的潛力。然而，儘管非洲對抗凝血藥物的需求龐大，但非洲在衛生基礎設施和取得藥物方面仍面臨挑戰。在亞太地區，中國和印度不斷提高的醫療意識和不斷上漲的醫療成本推動了對氟啶酮的需求。日本擁有完善的醫療體系，在強勁的研發活動的支持下，對氟二酮的需求穩定。最近對衛生基礎設施的投資以及對心血管疾病日益成長的興趣是該地區的主要驅動力。

FPNV定位矩陣

FPNV 定位矩陣對於評估供應商在全印度酮市場的定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可對 Full Indion 市場中供應商的當前狀態進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他關鍵指標。此外，該分析還提供了對該細分市場競爭力的寶貴見解，包括研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對氟二酮市場當前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行概述

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 需要抗凝血治療的病例增加
      • 改善並擴大全球醫療基礎設施
    • 抑制因素
      • 對副作用和與其他藥物相互作用的擔憂
    • 機會
      • 世界各地正在開發新的藥物輸送系統
      • 氟二酮進一步治療應用的研究
    • 任務
      • 嚴格的藥品核准監理流程
  • 市場區隔分析
    • 純度：全茚酮的純度優選 >98%，以滿足活性藥物成分 (API) 的嚴格要求
    • 應用：擴大氟二酮在抗凝血治療的應用
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章氟二酮市場：依純度

  • 介紹
  • 95%
  • 98%以上

第7章完整的印度酮市場：依應用分類

  • 介紹
  • 抗凝血治療
  • 持續性心房顫動
  • 肺動脈栓塞
  • 靜脈血栓症

第 8 章完整的 Indion 市場：依最終使用者分類

  • 介紹
  • 醫院/診所
  • 長期照護設施

第9章 美洲完整的印度酮市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太全印度市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲完整的印度酮市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Helixomer 獲得 NIH 200 萬美元津貼用於開發抗凝血劑
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-757B1C9CB035

[181 Pages Report] The Fluindione Market size was estimated at USD 919.90 million in 2023 and expected to reach USD 971.51 million in 2024, at a CAGR 5.69% to reach USD 1,355.51 million by 2030.

The fluindione market refers to the global industry landscape focused on the production, distribution, and application of Fluindione, an oral anticoagulant used primarily in treating and preventing thromboembolic diseases. This market encompasses pharmaceutical companies, healthcare providers, research institutions, and patients requiring anticoagulant therapy. Fluindione is conventionally used in clinical settings for preventing and managing thrombosis and embolism in patients. Its applications extend to patients requiring long-term anticoagulant therapy, such as those with atrial fibrillation, venous thromboembolism, and individuals at a high risk of forming blood clots. Growth in the fluindione market is influenced by factors, including the elevating prevalence of cardiovascular diseases, advancements in medical research, improvements and expansions in the global healthcare infrastructure, and greater awareness of thromboembolic diseases. However, the market faces limitations due to the potential side effects of Fluindione, such as bleeding risks and drug interactions. Regulatory challenges, stringent approval processes, and competition from newer anticoagulants pose significant hurdles. Additionally, patient compliance with long-term anticoagulant therapy remains a challenge. On the other hand, opportunities for the expansion of fluindione lie in the development of fluindione derivatives with improved efficacy and safety profiles, strategic collaborations between pharmaceutical companies and research institutions, and the Ongoing development of novel drug delivery systems globally.

KEY MARKET STATISTICS
Base Year [2023] USD 919.90 million
Estimated Year [2024] USD 971.51 million
Forecast Year [2030] USD 1,355.51 million
CAGR (%) 5.69%

Regional Insights

In North America, the US, in particular, has an increased prevalence of cardiovascular disorders, contributing to a substantial need for anticoagulants. Customer behavior in the US is strongly influenced by clinician recommendations, with a growing preference for drugs having fewer side effects and better patient outcomes. Both countries exhibit a robust research landscape, with numerous patents filed yearly, indicating vigorous innovation and a competitive market environment. The South American market is marked by gradual growth attributed to improving healthcare infrastructure and increasing awareness about conditions necessitating anticoagulation therapy. European countries have traditionally been strong markets for fluindione, attributed to well-established healthcare systems and high awareness regarding thromboembolic diseases. France, in particular, has a notable presence in the fluindione market with research and development initiatives. The Middle East and Africa present a varied landscape, with the Gulf countries showing potential for market expansion due to increasing healthcare investment and more accessible healthcare services. However, Africa faces challenges related to healthcare infrastructure and access to medications despite a noticeable need for anticoagulants. In APAC, rising healthcare awareness and increased healthcare expenditures in China and India drive the demand for fluindione. Japan, with its sophisticated healthcare system, shows a steady demand for fluindione, supported by robust research and development activities. Recent investments in healthcare infrastructure and a growing focus on cardiovascular diseases are key drivers in this region.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Fluindione Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising cases of conditions requiring anticoagulation therapy
      • Improvements and expansions in the global healthcare infrastructure
    • Market Restraints
      • Concerns related to adverse effects and interactions with other medications
    • Market Opportunities
      • Ongoing development of novel drug delivery systems globally
      • Research into additional therapeutic applications of fluindione
    • Market Challenges
      • Stringent regulatory processes for drug approval
  • Market Segmentation Analysis
    • Purity: Increasing preference for >=98% purity in fluindione for meeting stringent requirements for active pharmaceutical ingredients (APIs)
    • Application: Expanding application of fluindione for anticoagulating treatment
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Fluindione Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Fluindione Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Helixomer awarded $2M NIH grant for anticoagulant development

Raleigh's Helixomer has been awarded a significant USD 2 million grant by the National Institutes of Health (NIH) for the development of innovative anticoagulant drugs. The infusion of funds from the NIH, building on prior financial backing from the North Carolina Biotechnology Center and the university's Chancellor's Innovation Fund, propels Helixomer into further preclinical development, enhancing their trajectory towards commercialization. [Published On: 2023-12-14]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Fluindione Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Fluindione Market, highlighting leading vendors and their innovative profiles. These include 1PlusChem LLC, Angene, Cayman Chemical Company, Clearsynth, DC Chemicals, Henan Bon Industrial Co.,Ltd., Manus Aktteva Biopharma LLP, Merck KGaA, Prime Pharmaceuticals Pvt. Ltd., Shodhana Laboratories Pvt. Ltd., TargetMol Chemicals Inc., and TEBU-BIO LIMITED.

Market Segmentation & Coverage

This research report categorizes the Fluindione Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Purity
    • 95%
    • >= 98%
  • Application
    • Anticoagulating Treatment
    • Permanent Atrial Fibrillation
    • Pulmonary Embolism
    • Venous Thrombosis
  • End-User
    • Hospitals & Clinics
    • Long-Term Care Facilities
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising cases of conditions requiring anticoagulation therapy
      • 5.1.1.2. Improvements and expansions in the global healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns related to adverse effects and interactions with other medications
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing development of novel drug delivery systems globally
      • 5.1.3.2. Research into additional therapeutic applications of fluindione
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory processes for drug approval
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Purity: Increasing preference for >=98% purity in fluindione for meeting stringent requirements for active pharmaceutical ingredients (APIs)
    • 5.2.2. Application: Expanding application of fluindione for anticoagulating treatment
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Fluindione Market, by Purity

  • 6.1. Introduction
  • 6.2. 95%
  • 6.3. >= 98%

7. Fluindione Market, by Application

  • 7.1. Introduction
  • 7.2. Anticoagulating Treatment
  • 7.3. Permanent Atrial Fibrillation
  • 7.4. Pulmonary Embolism
  • 7.5. Venous Thrombosis

8. Fluindione Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals & Clinics
  • 8.3. Long-Term Care Facilities

9. Americas Fluindione Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Fluindione Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Fluindione Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Helixomer awarded $2M NIH grant for anticoagulant development
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. FLUINDIONE MARKET RESEARCH PROCESS
  • FIGURE 2. FLUINDIONE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FLUINDIONE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FLUINDIONE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL FLUINDIONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. FLUINDIONE MARKET DYNAMICS
  • FIGURE 7. GLOBAL FLUINDIONE MARKET SIZE, BY PURITY, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL FLUINDIONE MARKET SIZE, BY PURITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL FLUINDIONE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL FLUINDIONE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL FLUINDIONE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL FLUINDIONE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES FLUINDIONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES FLUINDIONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. FLUINDIONE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. FLUINDIONE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FLUINDIONE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FLUINDIONE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL FLUINDIONE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL FLUINDIONE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL FLUINDIONE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL FLUINDIONE MARKET SIZE, BY 95%, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL FLUINDIONE MARKET SIZE, BY 95%, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL FLUINDIONE MARKET SIZE, BY >= 98%, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL FLUINDIONE MARKET SIZE, BY >= 98%, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL FLUINDIONE MARKET SIZE, BY ANTICOAGULATING TREATMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL FLUINDIONE MARKET SIZE, BY ANTICOAGULATING TREATMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL FLUINDIONE MARKET SIZE, BY PERMANENT ATRIAL FIBRILLATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL FLUINDIONE MARKET SIZE, BY PERMANENT ATRIAL FIBRILLATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL FLUINDIONE MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL FLUINDIONE MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL FLUINDIONE MARKET SIZE, BY VENOUS THROMBOSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL FLUINDIONE MARKET SIZE, BY VENOUS THROMBOSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL FLUINDIONE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL FLUINDIONE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL FLUINDIONE MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL FLUINDIONE MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS FLUINDIONE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS FLUINDIONE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 37. ARGENTINA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 38. ARGENTINA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 41. ARGENTINA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 42. ARGENTINA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 47. BRAZIL FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 48. BRAZIL FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 51. CANADA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 52. CANADA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 53. CANADA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 54. CANADA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 55. MEXICO FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 56. MEXICO FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 57. MEXICO FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 58. MEXICO FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 59. MEXICO FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. MEXICO FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. UNITED STATES FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 62. UNITED STATES FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES FLUINDIONE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES FLUINDIONE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 78. AUSTRALIA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. AUSTRALIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 82. AUSTRALIA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 83. CHINA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 84. CHINA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 85. CHINA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. CHINA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. CHINA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 88. CHINA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 89. INDIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 90. INDIA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 91. INDIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 92. INDIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 93. INDIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 94. INDIA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 95. INDONESIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 96. INDONESIA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 97. INDONESIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 98. INDONESIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 99. INDONESIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 100. INDONESIA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 101. JAPAN FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 102. JAPAN FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 103. JAPAN FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 104. JAPAN FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 105. JAPAN FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. JAPAN FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. MALAYSIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 108. MALAYSIA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 109. MALAYSIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. MALAYSIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. MALAYSIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. MALAYSIA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 114. PHILIPPINES FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. PHILIPPINES FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. PHILIPPINES FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. SINGAPORE FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 120. SINGAPORE FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 121. SINGAPORE FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. SINGAPORE FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. SINGAPORE FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. SINGAPORE FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 126. SOUTH KOREA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. SOUTH KOREA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. SOUTH KOREA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. TAIWAN FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 132. TAIWAN FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 133. TAIWAN FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. TAIWAN FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. TAIWAN FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 136. TAIWAN FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 137. THAILAND FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 138. THAILAND FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 139. THAILAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. THAILAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. THAILAND FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 142. THAILAND FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 143. VIETNAM FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 144. VIETNAM FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 145. VIETNAM FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. VIETNAM FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. VIETNAM FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. VIETNAM FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 157. DENMARK FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 158. DENMARK FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 159. DENMARK FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. DENMARK FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. DENMARK FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 162. DENMARK FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 163. EGYPT FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 164. EGYPT FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 165. EGYPT FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 166. EGYPT FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 167. EGYPT FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 168. EGYPT FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 169. FINLAND FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 170. FINLAND FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 171. FINLAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. FINLAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. FINLAND FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. FINLAND FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. FRANCE FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 176. FRANCE FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 177. FRANCE FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 178. FRANCE FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 179. FRANCE FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. FRANCE FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. GERMANY FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 182. GERMANY FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 183. GERMANY FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. GERMANY FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. GERMANY FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. GERMANY FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. ISRAEL FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 188. ISRAEL FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 189. ISRAEL FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 190. ISRAEL FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 191. ISRAEL FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 192. ISRAEL FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 193. ITALY FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 194. ITALY FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 195. ITALY FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. ITALY FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. ITALY FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 198. ITALY FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 200. NETHERLANDS FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 202. NETHERLANDS FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 204. NETHERLANDS FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 205. NIGERIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 206. NIGERIA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 207. NIGERIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 208. NIGERIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 209. NIGERIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. NIGERIA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. NORWAY FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 212. NORWAY FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 213. NORWAY FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 214. NORWAY FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 215. NORWAY FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 216. NORWAY FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 217. POLAND FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 218. POLAND FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 219. POLAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 220. POLAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 221. POLAND FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 222. POLAND FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 223. QATAR FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 224. QATAR FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 225. QATAR FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. QATAR FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. QATAR FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. QATAR FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. RUSSIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 230. RUSSIA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 231. RUSSIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 232. RUSSIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 233. RUSSIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. RUSSIA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 236. SAUDI ARABIA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 238. SAUDI ARABIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. SAUDI ARABIA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH AFRICA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH AFRICA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH AFRICA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. SPAIN FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 248. SPAIN FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 249. SPAIN FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 250. SPAIN FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 251. SPAIN FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 252. SPAIN FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 253. SWEDEN FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 254. SWEDEN FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 255. SWEDEN FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 256. SWEDEN FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 257. SWEDEN FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 258. SWEDEN FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 260. SWITZERLAND FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 262. SWITZERLAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 264. SWITZERLAND FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 265. TURKEY FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 266. TURKEY FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 267. TURKEY FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. TURKEY FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. TURKEY FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. TURKEY FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED KINGDOM FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED KINGDOM FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED KINGDOM FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. FLUINDIONE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 284. FLUINDIONE MARKET, FPNV POSITIONING MATRIX, 2023